Home News Interviews Companies Videos Markets Subscribe

The Markets

Sort by Price Sort by Change ($)Sort by Change (%)

close X

Core One Labs Inc.

close X

Cybin Corp

close X

Field Trip Health

close X

Havn Life

close X

MINDCURE

close X

Mydecine Innovations Group

close X

NeonMind Biosciences Inc.

close X

Novamind Inc.

close X

Numinus

close X

Optimi Health

close X

Pharmather

close X

PsyBio Therapeutics

close X

Psyched Wellness

close X

Psyence Group

close X

Pure Extracts Corp

close X

Silo Wellness

close X

The Good Shroom Co

close X

Tryp Therapeutics

close X

Wesana Health

close X

Algernon Pharmaceuticals

close X

BetterLife Pharma

close X

Braxia Scientific Corp.

close X

Horizons ETFs Management Inc.

close X

Ketamine One

close X

Mind Medicine (MindMed)

close X

Mindset Pharma

close X

Nova Mentis Life Science

close X

Revive Therapeutics

close X

Seelos Therapeutics

close X

Small Pharma

close X

Compass Pathways

close X

EGF Theramed Health Corp

close X

Entheon Biomedical

close X

Lobe Sciences

close X

Pharmadrug Inc.

close X

Red Light Holland

Features

New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

News

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

News

Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings

News

Cybin to Present at the Emerging Growth Conference on June 23rd

GET THE HEADLINES + UPDATES

Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.

Thanks for subscribing!

Oops! Something went wrong while submitting the form.

Numinus

Field Trip Health

NeonMind Biosciences Inc.

Mydecine Innovations Group

Mind Medicine (MindMed)

TheraPsil

Revive Therapeutics

Nova Mentis Life Science

Psilotec Health Solutions

Algernon Pharmaceuticals

Aja Ventures

Horizons ETFs Management Inc.

Seelos Therapeutics

Mycrodose Therapeutics

Fluence

Braxia Scientific Corp.

Gilgamesh Pharmaceuticals

Molecular Science Corp.

2 3 5

Cookie Policy: We use cookies on this site to track usage and help improve the user experience. By continuing to use our site, you are agreeing to this policy.

Accept